Rachel Lenington

Rachel brings over 20 years of diverse leadership and management experience from a variety of sectors including global public health and biotech to her leadership of our portfolio strategy, partnerships and global product development efforts. She leverages this experience to advance and deliver on corporate, portfolio and product strategies and support Seattle Genetics’ transition to a global, multi-product oncology company.